These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 11921158

  • 1. Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it?
    Bullock R, Connolly C.
    Int J Geriatr Psychiatry; 2002 Mar; 17(3):288-9. PubMed ID: 11921158
    [No Abstract] [Full Text] [Related]

  • 2. Noncognitive symptoms and long-term treatment expectations for Alzheimer disease.
    Blesa R.
    Alzheimer Dis Assoc Disord; 2004 Mar; 18 Suppl 1():S9-16. PubMed ID: 15249843
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
    Rodda J, Morgan S, Walker Z.
    Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine?
    Sharma JC.
    Int J Clin Pract; 2002 Oct; 56(6):414-5. PubMed ID: 12166537
    [No Abstract] [Full Text] [Related]

  • 8. Maintaining functional and behavioral abilities in Alzheimer disease.
    Winblad B.
    Alzheimer Dis Assoc Disord; 2001 Aug; 15 Suppl 1():S34-40. PubMed ID: 11669508
    [Abstract] [Full Text] [Related]

  • 9. Featured CME topic: dementia. Medication update.
    Slagle MA.
    South Med J; 2001 Jul; 94(7):678-81. PubMed ID: 11531174
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacologic management of Alzheimer disease.
    Downey D.
    J Neurosci Nurs; 2008 Feb; 40(1):55-9. PubMed ID: 18330411
    [Abstract] [Full Text] [Related]

  • 11. Comments on Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil.
    McRae TD, Schwam EM.
    Curr Med Res Opin; 2002 Feb; 18(6):i-iii; author reply iv-vi. PubMed ID: 12442885
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Medical treatment of Alzheimer's disease].
    Johannsen P.
    Ugeskr Laeger; 2006 Oct 02; 168(40):3424-9. PubMed ID: 17032609
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative study of donepezil and rivastigmine.
    Grossberg G.
    Int J Clin Pract; 2003 Oct 02; 57(1):70-1; author reply 71. PubMed ID: 12587950
    [No Abstract] [Full Text] [Related]

  • 18. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R, Bergman H, Touchon J, Gambina G, He Y, Nagel J, Lane R.
    Curr Med Res Opin; 2006 Mar 02; 22(3):483-94. PubMed ID: 16574032
    [Abstract] [Full Text] [Related]

  • 19. Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease.
    Ritchie CW, Ames D, Clayton T, Lai R.
    Am J Geriatr Psychiatry; 2004 Mar 02; 12(4):358-69. PubMed ID: 15249273
    [Abstract] [Full Text] [Related]

  • 20. [Do medicines with aim to anti-Alzheimer favor the arisen of epileptic crisis? Discussion about 3 clinical cases].
    Roy M, Castro-Lionard K, Crawford-Achour E, Desseigne N, Beyens MN, Guy C, Imler D, Cornillon D.
    Therapie; 2011 Mar 02; 66(3):291-3. PubMed ID: 23189344
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.